ABOUT THIS EPISODE
The COVID-19 pandemic hit many developing countries especially hard, overwhelming already stretched health systems while devastating tourism-dependent economies. Looking ahead, widely available therapeutics could be game-changers – keeping people out of hospitals, easing pressure on health systems, and helping keep economies open. This episode explores the global collaboration needed to ensure pandemic preparedness reaches everyone, everywhere.
What You'll Learn:
Pacific resilience - How Pacific Island nations' experience with natural disasters creates unique strengths and vulnerabilities in pandemic response.
Health system flexibility - Why limited resources sometimes breed innovation, and how Pacific health workers adapt to multiple crisis situations.
Therapeutic advantage - How having treatments available could help countries reopen borders and return to normal faster than vaccines alone.
Global collaboration in action - The cross-border support systems that make Pacific pandemic response possible, from emergency medical teams to resource sharing.
Pandemic agreement breakthrough - The world's second global health treaty and how it will ensure equitable access to vaccines, diagnostics, and therapeutics.
The preparedness gap - Why high-income countries failed while some "poorly prepared" nations succeeded, and what this teaches us about true pandemic readiness.
Investment ecosystem revealed - The complex pipeline from university research to patient treatment, and why all stages matter.
Featured Experts
Dr. Gina Samaan - WHO Regional Emergency Director explaining how Pacific health systems adapt to constant challenges and why therapeutics are crucial for future preparedness
Professor Michel Kazatchkine - Former Global Fund Executive Director and Member of the Independent Panel for Pandemic Preparedness, sharing lessons from COVID-19's devastating impact on global health programs.
The technology exists. The investment is flowing. The question now is: will we be ready?
Off Script is hosted by Dr. Matt Agnew and produced by the Cumming Global Centre for Pandemic Therapeutics, part of the Peter Doherty Institute for Infection and Immunity.
